Current approaches for identifying high-risk non-muscle invasive bladder cancer.
作者： Oner Sanli , Yair Lotan
DOI: 10.1080/14737140.2018.1432358
关键词: Pathological 、 Oncology 、 Urinary system 、 Subtyping 、 Carcinoma in situ 、 Cancer 、 Cystoscopy 、 Bladder cancer 、 Medicine 、 Urine cytology 、 Internal medicine
摘要: ABSTRACTIntroduction: Management of high risk non-muscle invasive bladder cancer (NMIBC) is challenging. It vital to detect recurrences early and predict which tumors are likely progress.Areas covered: This manuscript reviews the current approaches available for detection surveillance NMIBCs. A literature review was utilized evaluate factors recurrence progression as well evaluating including pathological aspects NMIBC, molecular subtyping, methods tumor visualization, urine cytology, urinary markers, tissue markers scoring systems nomograms.Expert commentary: Clinical still mainstay prediction progression. However, genomic information such subtyping may improve understanding prognosis. White light cystoscopy a dominant approach but enhanced superior especially carcinoma in situ. Urinar...
elsevier.com
sci-hub.se 参考文章(99)
Kyungeun Kim, Bong Hee Park, Yong Mee Cho, Jae Y. Ro, Heounjeong Go, Jung Weon Shim, Jae Lyun Lee, Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer. International Journal of Clinical and Experimental Pathology. ,vol. 8, pp. 743- 750 ,(2015)
G Nabi, J Cook, L Vale, G Mowatt, S Zhu, M Kilonzo, C Boachie, C Fraser, TRL Griffiths, J N'Dow, Effectiveness and cost-effectiveness of arthroscopic lavage in the treatment of osteoarthritis of the knee: a mixed methods study of the feasibility of conducting a surgical placebo-controlled trial (the KORAL study). Health Technology Assessment. ,vol. 14, pp. 1- 180 ,(2010) , 10.3310/HTA14040
Samantha Cambier, Richard J. Sylvester, Laurence Collette, Paolo Gontero, Maurizio A. Brausi, George van Andel, Wim J. Kirkels, Fernando Calais Da Silva, Willem Oosterlinck, Stephen Prescott, Ziya Kirkali, Philip H. Powell, Theo M. de Reijke, Levent Turkeri, Sandra Collette, Jorg Oddens, EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin European Urology. ,vol. 69, pp. 60- 69 ,(2016) , 10.1016/J.EURURO.2015.06.045
Bedeir Ali-El-Dein, Prasanna Sooriakumaran, Quoc-Dien Trinh, Tamer S. Barakat, Adel Nabeeh, El-Housseiny I. Ibrahiem, Construction of predictive models for recurrence and progression in >1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre BJU International. ,vol. 111, pp. E331- E341 ,(2013) , 10.1111/BJU.12026
Pengfei Shen, Jie Yang, Wuran Wei, Yutao Li, Dingming Li, Hao Zeng, Jia Wang, None, Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis. BJUI. ,vol. 110, ,(2012) , 10.1111/J.1464-410X.2011.10892.X
Björn L. Isfoss, The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard BJU International. ,vol. 108, pp. 1703- 1707 ,(2011) , 10.1111/J.1464-410X.2011.10485.X
Joo Yong Lee, Kang Su Cho, Dong Hyuk Kang, Hae Do Jung, Jong Kyou Kwon, Cheol Kyu Oh, Won Sik Ham, Young Deuk Choi, A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging. BMC Cancer. ,vol. 15, pp. 566- 566 ,(2015) , 10.1186/S12885-015-1571-8
Bas W.G. van Rhijn, Liyang Liu, André N. Vis, Peter J. Bostrom, Tahlita C.M. Zuiverloon, Neil E. Fleshner, Madelon N.M. van der Aa, Sultan S. Alkhateeb, Chris H. Bangma, Michael A.S. Jewett, Ellen C. Zwarthoff, Bharati Bapat, Theo H. van der Kwast, Alexandre R. Zlotta, Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer. BJUI. ,vol. 110, pp. 1169- 1176 ,(2012) , 10.1111/J.1464-410X.2012.10996.X
Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, Matthew R. Sydes, Alison Birtle, Sigurdur Gudjonsson, Cosimo De Nunzio, Kikuo Okamura, Eero Kaasinen, Eduardo Solsona, Bedeir Ali-El-Dein, Can Ali Tatar, Brant A. Inman, James N’Dow, Jorg R. Oddens, Marek Babjuk, Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? European Urology. ,vol. 69, pp. 231- 244 ,(2016) , 10.1016/J.EURURO.2015.05.050
Polat Turker, Peter J. Bostrom, Marcelo L. Wroclawski, Bas van Rhijn, Hannes Kortekangas, Cynthia Kuk, Tuomas Mirtti, Neil E. Fleshner, Michael A. Jewett, Antonio Finelli, Theo Vander Kwast, Andy Evans, Joan Sweet, Matti Laato, Alexandre R. Zlotta, Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome BJUI. ,vol. 110, pp. 804- 811 ,(2012) , 10.1111/J.1464-410X.2012.10939.X